To evaluate the impact of hsBCL9z96 treatment on antigen-specific CD8+ T cells in vivo, we established a murine model with MC38 tumor cells overexpressing ovalbumin (OVA) (MC38-OVA). Here, CD8A is linked to neoplasm.